Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Total Current Liabilities (2010 - 2026)

Vericel (VCEL) posted Total Current Liabilities of $52.5 million for Q2 2026, up 11.4% sequentially from $47.2 million in Q1 2026, and up 27.72% YoY from $41.1 million in Q2 2025.

Analysis

Vericel (VCEL) Total Current Liabilities (2010 - 2026) Analysis & Trends

Vericel has reported Total Current Liabilities for 17 years, with the latest figure at $52.5 million in Q2 2026.

  • Quarterly Total Current Liabilities rose 27.72% year-over-year to $52.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $52.5 million (up 27.72% YoY) and the FY2025 annual result came in at $49.1 million, down 2.26% from the prior year.
  • Total Current Liabilities grew to $52.5 million in Q2 2026 per VCEL's latest filing, from $47.2 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $52.5 million in Q2 2026 and troughed at $21.7 million in Q1 2022.
  • A 5-year average of $39.1 million and a median of $40.3 million in 2025 frame the typical range for Total Current Liabilities.
  • The widest YoY moves for Total Current Liabilities: up 43.8% in 2022, down 6.45% in 2022.
  • Over 5 years, Total Current Liabilities stood at $37.5 million in 2022, then climbed by 22.12% to $45.7 million in 2023, then gained by 9.92% to $50.3 million in 2024, then fell by 2.26% to $49.1 million in 2025, then rose by 6.88% to $52.5 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $52.5 million, $47.2 million, and $49.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 52.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.53 Mn
Mar 31, 2026 47.16 Mn
Dec 31, 2025 49.15 Mn
Sep 30, 2025 45.58 Mn
Jun 30, 2025 41.13 Mn
Mar 31, 2025 39.45 Mn
Dec 31, 2024 50.29 Mn
Sep 30, 2024 41.35 Mn
Jun 30, 2024 43.86 Mn
Mar 31, 2024 36.47 Mn
Dec 31, 2023 45.75 Mn
Sep 30, 2023 35.95 Mn
Jun 30, 2023 35.61 Mn
Mar 31, 2023 28.75 Mn
Dec 31, 2022 37.46 Mn
Sep 30, 2022 27.00 Mn
Jun 30, 2022 25.01 Mn
Mar 31, 2022 21.73 Mn
Dec 31, 2021 26.05 Mn
Sep 30, 2021 18.83 Mn